188 related articles for article (PubMed ID: 34517544)
21. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
22. Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma.
Alghamdi RA; Al-Zahrani MH
Saudi J Biol Sci; 2023 Apr; 30(4):103596. PubMed ID: 36879671
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatic Analysis for Influential Core Gene Identification and Prognostic Significance in Advanced Serous Ovarian Carcinoma.
Song C; Kim KB; Lee JH; Kim S
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577856
[No Abstract] [Full Text] [Related]
24. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
25. Identification of dysregulated miRNAs-genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms.
Kadkhoda S; Darbeheshti F; Tavakkoly-Bazzaz J
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1286. PubMed ID: 32886452
[TBL] [Abstract][Full Text] [Related]
26. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
27. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
[TBL] [Abstract][Full Text] [Related]
29.
Hu Q; Gao M; Zhang D; Leng B; Wang J; Liu Q; He S; Zhi W; Zhou Z
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34958106
[TBL] [Abstract][Full Text] [Related]
30. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
31. Identification of key genes and miRNA-mRNA regulatory networks associated with bone marrow immune microenvironment regulations in multiple myeloma by integrative bioinformatics analysis.
Tuerxun N; Wang J; Qin YT; Zhao F; Wang H; Qu JH; Uddin MN; Hao JP
Hematology; 2022 Dec; 27(1):506-517. PubMed ID: 35536760
[TBL] [Abstract][Full Text] [Related]
32. Four genes relevant to pathological grade and prognosis in ovarian cancer.
Pan X; Chen Y; Gao S
Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways.
Fei H; Chen S; Xu C
J Ovarian Res; 2020 Jul; 13(1):82. PubMed ID: 32693821
[TBL] [Abstract][Full Text] [Related]
34. Identification of core genes in ovarian cancer by an integrative meta-analysis.
Li W; Liu Z; Liang B; Chen S; Zhang X; Tong X; Lou W; Le L; Tang X; Fu F
J Ovarian Res; 2018 Nov; 11(1):94. PubMed ID: 30453999
[TBL] [Abstract][Full Text] [Related]
35. Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis.
Hao W; Zhao H; Li Z; Li J; Guo J; Chen Q; Gao Y; Ren M; Zhao X; Yue W
J Ovarian Res; 2021 Mar; 14(1):46. PubMed ID: 33726773
[TBL] [Abstract][Full Text] [Related]
36. [MiR-4772 modulates tumor immune microenvironment by regulating immune- related genes in ovarian cancer].
Zhao A; Su Y; Fu D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1638-1645. PubMed ID: 36504056
[TBL] [Abstract][Full Text] [Related]
37. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
[TBL] [Abstract][Full Text] [Related]
38.
Lou J; Wei L; Wang H
Int J Gen Med; 2022; 15():1743-1763. PubMed ID: 35221714
[TBL] [Abstract][Full Text] [Related]
39. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
40. Identifying key transcription factors and miRNAs coregulatory networks associated with immune infiltrations and drug interactions in idiopathic pulmonary arterial hypertension.
Li Q; Hujiaaihemaiti M; Wang J; Uddin MN; Li MY; Aierken A; Wu Y
Math Biosci Eng; 2023 Jan; 20(2):4153-4177. PubMed ID: 36899621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
